Shandong Jincheng Pharmaceutical and Chemical Co Ltd Market Cap ($653.85 Million)
Market Cap & Net Worth: Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233)
Shandong Jincheng Pharmaceutical and Chemical Co Ltd market cap. Shandong Jincheng Pharmaceutical and Chemical Co Ltd (SHE:300233) has a market capitalization of $653.85 Million (CN¥4.47 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #10622 globally and #2838 in its home market, demonstrating a -1.36% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Jincheng Pharmaceutical and Chemical Co Ltd's stock price CN¥11.64 by its total outstanding shares 383874587 (383.87 Million). Also see Shandong Jincheng Pharmaceutical and Che cash flow conversion for how efficiently the company converts equity into cash flow.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Market Cap History (2015–2026)
Shandong Jincheng Pharmaceutical and Chemical Co Ltd market cap history from 2015 to 2026. Data shows change from $1.68 Billion to $653.85 Million (-8.18% CAGR). Check current stock price of Shandong Jincheng Pharmaceutical and Che for real-time trading data and today's change.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Shandong Jincheng Pharmaceutical and Che net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.29x
Shandong Jincheng Pharmaceutical and Chemical Co Ltd's market cap is 0.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
17.79x
Shandong Jincheng Pharmaceutical and Chemical Co Ltd's market cap is 17.79 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.26 Billion | $1.42 Billion | $159.39 Million | 0.89x | 7.92x |
| 2017 | $971.53 Million | $2.79 Billion | $286.30 Million | 0.35x | 3.39x |
| 2018 | $719.00 Million | $3.01 Billion | $263.86 Million | 0.24x | 2.72x |
| 2019 | $1.06 Billion | $2.79 Billion | $203.29 Million | 0.38x | 5.21x |
| 2020 | $1.03 Billion | $2.96 Billion | -$488.84 Million | 0.35x | N/A |
| 2021 | $1.58 Billion | $3.14 Billion | $107.98 Million | 0.50x | 14.62x |
| 2022 | $1.24 Billion | $3.51 Billion | $273.37 Million | 0.36x | 4.55x |
| 2023 | $917.62 Million | $3.54 Billion | $174.71 Million | 0.26x | 5.25x |
| 2024 | $674.08 Million | $3.37 Billion | $196.78 Million | 0.20x | 3.43x |
| 2025 | $785.86 Million | $2.74 Billion | $44.19 Million | 0.29x | 17.79x |
Competitor Companies of 300233 by Market Capitalization
Companies near Shandong Jincheng Pharmaceutical and Chemical Co Ltd in the global market cap rankings as of November 5, 2026. Also see 300233 asset base for a full breakdown of the balance sheet.
Key companies related to Shandong Jincheng Pharmaceutical and Chemical Co Ltd by market ranking:
- BASF SE (F:BASA): Ranked #591 globally with a market cap of $45.63 Billion USD ( €39.03 Billion EUR).
- BASF SE (XETRA:BAS): Ranked #609 globally with a market cap of $44.62 Billion USD ( €38.17 Billion EUR).
- Ningxia Baofeng Energy Group Co Ltd (SHG:600989): Ranked #1100 globally with a market cap of $23.88 Billion USD ( CN¥163.17 Billion CNY).
- Dow Inc (NYSE:DOW): Ranked #1115 globally with a market cap of $23.57 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #591 | BASF SE | F:BASA | $45.63 Billion | €13.40 |
| #609 | BASF SE | XETRA:BAS | $44.62 Billion | €54.30 |
| #1100 | Ningxia Baofeng Energy Group Co Ltd | SHG:600989 | $23.88 Billion | CN¥22.25 |
| #1115 | Dow Inc | NYSE:DOW | $23.57 Billion | $32.70 |
Market Capitalization of Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2015–2026)
Market capitalization of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2015 to today. Between 2015 and today, Shandong Jincheng Pharmaceutical and Chemical Co Ltd's market cap moved from $1.68 Billion to $ 653.85 Million, with a yearly change of -8.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥653.85 Million | -16.80% |
| 2025 | CN¥785.86 Million | +16.58% |
| 2024 | CN¥674.08 Million | -26.54% |
| 2023 | CN¥917.62 Million | -26.29% |
| 2022 | CN¥1.24 Billion | -21.16% |
| 2021 | CN¥1.58 Billion | +53.98% |
| 2020 | CN¥1.03 Billion | -3.16% |
| 2019 | CN¥1.06 Billion | +47.29% |
| 2018 | CN¥719.00 Million | -25.99% |
| 2017 | CN¥971.53 Million | -23.06% |
| 2016 | CN¥1.26 Billion | -24.94% |
| 2015 | CN¥1.68 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Shandong Jincheng Pharmaceutical and Chemical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $653.85 Million USD |
| MoneyControl | $653.85 Million USD |
| MarketWatch | $653.85 Million USD |
| marketcap.company | $653.85 Million USD |
| Reuters | $653.85 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shandong Jincheng Pharmaceutical and Chemical Co Ltd
Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China.